> Harvard's Wyss Institute for Biologically Inspired Engineering is spinning out its "organ-on-a-chip" technology into a private company, called Emulate, Inc. More
> The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, has awarded SRI International with a $49 million, 7-year contract to conduct preclinical development of potential therapies for HIV and AIDS. Release
> Investment in HIV prevention research fell $50 million, or 4%, to $1.26 billion in 2013, due to declining investments by the U.S. and European governments. Report
> Vanderbilt University researchers have found that a therapeutic compound derived from a certain type of bacteria in the gut is able to inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice. Story